PP-C8

PP-C8 is a potent and selective PROTAC that degrades CDK12 and Cyclin K with DC50 values of approximately 410 nM. It demonstrates synergistic antiproliferative activity with PARP inhibitors in triple-negative breast cancer models, making it a valuable chemical probe for oncology research targeting transcription-associated kinases.